Live Webinar
From Silent Killer to Curable Disease: The New Era of Hepatitis C
|
From Silent Killer to Curable Disease: The New Era of Hepatitis C
1.5 CE Hours
Intermediate
$0
References
References
- U.S. Preventive Services Task Force. (2020). Screening for hepatitis C virus infection in adolescents and adults: Recommendation statement. JAMA, 323(10), 970–975. https://doi.org/10.1001/jama.2020.1123
- American Academy of Family Physicians. (2021). Screening for hepatitis C virus infection in adolescents and adults. https://www.aafp.org/pubs/afp/issues/2021/1200/p626.html
- American Association for the Study of Liver Diseases, & Infectious Diseases Society of America. (2023). HCV guidance: Recommendations for testing, managing, and treating hepatitis C. https://www.hcvguidelines.org
- Chhatwal, J., Chen, Q., Wang, X., Ayer, T., Zhuo, Y., Janjua, N. Z., & Kanwal, F. (2019). Assessment of the feasibility and cost of hepatitis C elimination in the United States. JAMA Network Open, 2(5), e193213. https://doi.org/10.1001/jamanetworkopen.2019.3213
- Hofmeister, M. G., Rosenthal, E. M., Barker, L. K., Rosenberg, E. S., Barranco, M. A., Hall, E. W., Edlin, B. R., Mermin, J., Ward, J. W., & Ryerson, A. B. (2019). Estimating prevalence of hepatitis C virus infection in the United States, 2013–2016. Hepatology, 69(3), 1020–1031. https://doi.org/10.1002/hep.30297